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Dear Sir,
I am Dr. Peter Mojzis from Premium Clinic in Teplice(Czech Republic). I write to present the results of a
comparative study of clinical outcomes obtained with two
different types of tinted intraocular lenses (IOLs), yellow-
violet-tinted IOLs.
IOLs containing a yellow chromophore that filters
simultaneously ultra violet (UV) and blue light were developed
several years ago in the attempt of avoiding that blue and
violet visible light reached the retina in the pseudophakic eye[1].
These blue-light filtering IOLs have shown good visual and
contrast sensitivity outcomes postoperatively [2-3], but some
side effects in relation with the steady reduction in the
transmission of short-wavelength visible light have been
reported by some authors, such as alterations in colour
perception[4] or a detrimental effect of the circadian rhythm[5].
For this reason, a new concept of light-filtering IOL has been
recently developed that consists of introducing in the IOL
material a violet absorber that allows full transmission of
healthy blue light and theoretically avoiding the side effects
of yellow-tinted IOLs. However, to this date, there are no
studies reporting the clinical outcomes with this new
modality of IOL, violet light filtering or violet-tinted IOLs.
We conducted in our clinic a prospective randomized
comparative study enrolling 55 eyes of 28 patients
undergoing cataract surgery and ranging in age from 61 to
84y (mean age: 71.9y). Two groups were created according
to the model of IOL implanted: the yellow IOL group,
including 22 eyes of 11 patients implanted with the
monofocal C-loop blue-light filtering IOL (Acrysof IQ
SN60WF, Alcon) that reduces the transmittance for the blue
light wavelengths from 62% at 400 nm to 23% at 475 nm,
and the violet IOL group, including 33 eyes of 17 patients
implanted with the monofocal plate-haptic violet filtering
IOL (CT Asphina 404V, Carl Zeiss Meditec) that reduces
transmittance of violet light wavelengths in the range from
400 nm to 440 nm. Inclusion criteria were patients with
cataract or presbyopic/pre-presbyopic patients suitable for
refractive lens exchange seeking for spectacle independence.
Exclusion criteria were patients with history of glaucoma or
retinal detachment, corneal disease, irregular corneal
astigmatism, abnormal iris, macular degeneration or
retinopathy, neurophthalmic disease, history of ocular
inflammation or previous ocular surgery. All patients were
adequately informed and signed a consent form. The study
adhered to the tenets of the Declaration of Helsinki and it
was approved by the local ethics committee.
Before surgery, a complete ophthalmologic examination was
performed in all cases, including manifest refraction,
automated keratometry, uncorrected (UDVA) and corrected
distance visual acuity (CDVA) testing (ETDRS charts),
Goldmann applanation tonometry, slit-lamp examination,
ocular aberrometry (OPD scan III, Nidek), corneal
topography (OPD scan III, Nidek), biometry (IOL Master v.4.3,
Carl Zeiss Meditec), contrast sensitivity measurements under
photopic (85 cd/m2) and mesopic conditions (3 cd/m2, CSV
1000), and funduscopy.
All surgeries were performed by the same experienced
surgeon (Mojzis P) using a standard technique of sutureless
micro-coaxial 2.4-mm incision phacoemulsification in the
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yellow IOL group and a microincision (2.0-mm)
phacoemulsification technique in the violet IOL group.
Patients were revised postoperatively the day after surgery, at
1mo and 3mo after surgery. The postoperative examination
protocol at 3mo was identical to the preoperative protocol.
No statistically significant differences between groups were
present preoperatively in sphere, spherical equivalent, mean
keratometry, axial length or anterior chamber depth( 逸0.05).
Likewise, no statistically significant differences between
groups were found in IOL power ( =0.46). Only a small in
magnitude but statistically significant difference between
groups was found in preoperative manifest cylinder (-0.48依
0.27 D yellow IOL group -0.73依0.47 D violet IOL group,
=0.03).
Table 1 summarizes the 3-month postoperative visual acuity
and refraction data in the two groups of eyes evaluated. No
statistically significant differences between groups were
found in postoperative UDVA ( =0.81) and CDVA ( =0.64).
Likewise, no significant differences between groups were
found in postoperative sphere ( =0.10) and spherical
equivalent ( =0.06). Furthermore, no statistically significant
differences between groups were found in postoperative
manifest cylinder ( =0.93), which was consistent with the
lack of statistical significance for the difference between
groups in corneal astigmatism ( =0.81).
Significantly better photopic contrast sensitivities were
observed in the yellow IOL group preoperatively compared to
the violet IOL group for the spatial frequencies of 3 ( =0.03)
and 6 cycles/毅 ( =0.04) (Figure 1). Postoperatively, only the
photopic contrast sensitivity for 12 cycles/毅 ( =0.01) was
found to be significantly better in the yellow IOL group
compared to the violet IOL group (1.5 cycles/毅 , =0.12;
3 cycles/毅, =0.08; 6 cycles/毅, =0.10; 12 cycles/毅, =0.82;
18 cycles/毅, =0.24) (Figure 1). Regarding mesopic contrast
sensitivity, no statistically significant differences were found
between groups preoperatively ( 逸0.44) (Figure 1). In
contrast, better mesopic contrast sensitivities were found
postoperatively in the yellow IOL group compared to the
violet IOL group for the spatial frequencies of 3 ( =0.03)
and 12 cycles/毅 ( =0.02) (Figure 1).
Preoperatively, no statistically significant differences in any
internal and ocular aberrometric term was found ( 逸0.054),
except for internal spherical aberration Zernike term ( =0.003).
Postoperatively, no statistically significant differences were
found in any internal and ocular aberrometric term ( 逸
0.25), except for the Zernike terms corresponding to internal
and ocular spherical aberration ( <0.001).
Both tinted IOLs provided excellent distance visual
outcomes, with mean 3-month postoperative UDVA and
CDVA values around 0.10 (to 20/25) and 0.00 (to 20/20)
logMAR, respectively. This confirms the ability of these two
aspheric tinted IOLs of providing a good visual outcome due
to a predictable correction of the spherocylindrical error. No
statistically significant differences were found in the visual
and refractive outcomes obtained with both IOLs, showing a
similar postoperative variability. Comparing with the results
reported by previous authors, our UDVA and CDVA
outcomes with the two types of IOL evaluated were
comparable to those obtained in previous series evaluating
different yellow-tinted IOLs [2-3]. Likewise, our results were
consistent with those reported for other types of aspheric
IOLs without yellow tinting[6-7]. Regarding contrast sensitivity,
some differences were observed preoperatively between
yellow and violet IOL groups possibly due to discrepancies in
the type and density of cataract in each group.
Postoperatively, significantly better values of photopic
contrast sensitivity were found for the spatial frequency of
12 cycles/毅 in those eyes implanted with the yellow IOL.
Likewise, better mesopic contrast sensitivity for the spatial
frequency of 3 cycles/毅 was found in the yellow IOL group
compared to the violet IOL group. This suggests that the
optical performance of the yellow IOL may be potentially
better than that of the violet IOL, leading to an improved
contrast sensitivity outcome. Kara-Junior [3] compared
the levels of photopic and scotopic contrast sensitivity in
patients implanted with a yellow-tinted IOL in one eye and
Table 1 Comparative table showing the 3-month postoperative visual and refractive outcomes of eyes included in the yellow 
and violet IOL groups. 
Yellow IOL group Violet IOL group 
Parameters 
Mean (SD) Median (range) Mean (SD) Median (range) 
P 
LogMAR UDVA 0.14 (0.19) 0.10 (0.00 to 0.60) 0.10 (0.14) 0.10 (-0.10 to 0.50) 0.81b 
LogMAR CDVA 0.00 (0.04) 0.00 (-0.10 to 0.10) 0.01 (0.06) 0.00 (-0.10 to 0.20) 0.64b 
Sphere (D) -0.02 (0.79) +0.25 (-1.75 to 1.50) -0.34 (0.61) -0.50 (-1.75 to 1.50) 0.10a 
Cylinder (D) -0.31 (0.24) -0.25 (-0.75 to 0.00) -0.36 (0.38) -0.25 (-1.50 to 0.00) 0.93b 
Spherical equivalent (D) -0.18 (0.78) +0.06 (-2.00 to 1.13) -0.52 (0.57) -0.63 (-1.75 to 1.00) 0.06a 
Corneal astigmatism (D) 0.52 (0.22) 0.52 (0.05 to 0.87) 0.50 (0.24) 0.49 (0.15 to 1.07) 0.81a 
SD: Standard deviation; D: Diopters; UDVA: Uncorrected distance visual acuity; CDVA: Corrected distance visual acuity. aStudent’s 
t-test; bMann-Whitney U test. 
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Figure 1 Mean preoperative (A) and postoperative (B) contrast sensitivity function measured under photopic (top) and mesopic
(bottom) conditions in the yellow IOL (black line) and violet IOL (grey line) groups.
with a non-tinted IOL in the fellow eye and did not detect
significant differences. Leibovitch [2] and Rodr侏guez-
Galietero [8] obtained a similar outcome but comparing
the contrast sensitivity outcomes in eyes implanted with
yellow-tinted and clear IOLs. In contrast, Niwa [9] found
in another comparative study that a yellow-tinted IOL
provided an improved contrast sensitivity in the middle
spatial frequencies of 6 and 12 cycles/毅 in photopic and mesopic
conditions compared to the outcomes of non-tinted IOL.
Regarding the aberrometric outcomes, higher levels of
postoperative higher order aberrations were observed in the
group of eyes implanted with the violet IOL compared to the
yellow IOL, although the difference was only statistical
significant for primary spherical aberration. Specifically, eyes
implanted with the yellow IOL showed more negative
internal spherical aberration leading to an ocular level of
spherical aberration of almost zero. Therefore, this IOL
provided a more effective compensation for the corneal
spherical aberration. This is consistent with previous studies
that have confirmed the ability of this yellow IOL to
compensate this type of aberration [10]. Liu [10] found in a
comparative study that the aspheric yellow IOL evaluated in
our series induced significantly less spherical aberration and
provided better contrast sensitivity, especially under mesopic
conditions, than another yellow-tinted but spherical IOL. In
our study, the difference in postoperative contrast sensitivity
between yellow and violet IOLs may be due to the difference
in the level of residual spherical aberration.
In conclusion, the yellow- and violet-tinted IOLs evaluated in
our study are able to provide an effective distance visual
restoration after cataract surgery, although the yellow IOL
seems to provide a better visual quality due to the
optimization of the postoperative level of spherical
aberration. Future studies should be performed to confirm
these results in larger samples sizes and with a longer
follow-up. Likewise, the potential effect of changes in
chromatic aberration with these tinted IOLs should be
evaluated in future series.
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